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Postdoctoral Position.—Department of Molecular and
Medical Genetics, Oregon Health Sciences University,
Portland. Study the molecular bases of human genetic
disorders of brain iron metabolism. See WWW: http://
www.ohsu.edu/som-MedGen/gensjh.htm. Requires a
strong background in molecular biology, enthusiasm,
and independence. Send C.V. and three letters of refer-
ence to: Dr. Susan Hayflick, Department of Molecular
and Medical Genetics, L-103a, Oregon Health Sciences
University, 3181 S.W. Sam Jackson Park Road, Portland,
OR 97201-3098; E-mail: hayflick@ohsu.edu. OHSU is
an equal opportunity employer.
Medical Genetics. — The Department of Molecular and
Medical Genetics, Oregon Health Sciences University,
Portland, seeks individuals who have demonstrated re-
search excellence in eukaryotic genetics. Applicants with
special expertise in molecular and developmental genet-
ics are encouraged to apply, to complement existing pro-
grams. Applicants should include a C.V., a brief descrip-
tion of research accomplishments and future research
goals, and the names of three references. The deadline
is July 15, 1999. Please address applications to: Dr. Su-
san Olson, c/o Janice Blouse, Department of Molecular
and Medical Genetics, L103, Oregon Health Sciences
University, 3181 S.W. Sam Jackson Park Road, Portland,
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Director, Cytogenetics Laboratory.—The Department of
Pediatrics and growing Program in Human Genetics of
the University of Oklahoma Health Sciences Center,
Oklahoma City, seek a bc/be academic cytogeneticist to
expand an established service laboratory and to lead its
research and educational mission. Faculty rank and com-
pensation commensurate with experience. Please submit
C.V., letter of interest, and names of three references to:
Dr. John J. Mulvihill, Department of Pediatrics, Chil-
dren’s Hospital of Oklahoma, Room B2418, 940 NE
13th Street, Oklahoma City, OK 73104; E-mail: john
-mulvihill@ouhsc.edu. OUHSC is an EEO/AA/ADA em-
ployer; women and minorities are encouraged to apply.
Clinical Cytogenetics Laboratory Director.—The Divi-
sion of Laboratory and Transfusion Medicine, Depart-
ment of Pathology, Beth Israel Deaconess Medical Cen-
ter, Harvard Medical School, Boston, seeks a Ph.D. or
M.D. to direct a full-service academic cytogenetics lab-
oratory. Major laboratory areas include prenatal testing
of amniotic fluid specimens and chorionic villus samples;
postnatal testing of peripheral bloods, fibroblasts, and
other tissues; and cytogenetics of cancer specimens. The
applicant needs to be certified (or board-eligible), by the
American Board of Medical Genetics, in clinical cyto-
genetics. Experience in molecular cytogenetics is essen-
tial; experience in molecular genetics is desirable. The
successful applicant will participate in teaching at the
medical school and hospital. Harvard Medical School
faculty appointment (full-time) is commensurate with
experience. Involvement in funded research is encour-
aged. Reply with C.V. to: Dr. Margot S. Kruskall, Beth
Israel Deaconess Medical Center, Yamins Building,
Room 309, 330 Brookline Avenue, Boston, MA 02215.
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Clinical Geneticist.—The Department of Medical Ge-
netics in the Henry Ford Medical Group, Detroit, is seek-
ing an ABMG BC/BE clinical geneticist. The successful
candidate will be a pediatrician or internist with strong
teaching or research interests. The primary responsibility
will be clinical, as pediatric, adult, and prenatal genetics
clinics are held daily, including outreach clinics and dis-
ease-specific cancer and neurogenetics clinics. The clinics
are supported by nationally recognized DNA diagnostic
and cytogenetics laboratories. The department serves the
Henry Ford Health System (the largest integrated med-
ical system in Michigan), Children’s Hospital of Mich-
igan, and many other hospitals and clinics throughout
southeast Michigan. Medical Genetics employs 16 pro-
fessional staff, including 5 clinical geneticists, 2 Ph.D.
medical/laboratory geneticists, 5 genetic counselors, and
4 genetic nurses. We have an RRC-approved Clinical
Genetics Residency Training Program and an ABMG-
accredited Ph.D. training program in medical genetics,
cytogenetics, and molecular genetics. Research oppor-
tunities are abundant. HFHS is an affiliate of Case West-
ern Reserve University, and faculty appointments are
available through CWRU and Wayne State University.
The compensation is competitive and commensurate
with experience, and the benefit package is excellent.
Henry Ford Health System is an equal opportunity em-
ployer. Send a C.V. and letter of interest to: Dr. Daniel
L. Van Dyke, Chair, Department of Medical Genetics,
Henry Ford Medical Group, 2799 West Grand Boule-
vard, Detroit, MI 48202.
CONFERENCE
British Human Genetics Conference.—To be held on the
27–29 September, 1999, at the University of York, Eng-
land. There will be special sessions on animal models:
opportunities and limitations, telomeres and telomerase,
and cross-cultural counselling; a joint symposium with
the Cancer Family Study Group — How do faulty genes
cause cancer?—workshops, including CF—10 years
on and DNA breakage and recombination at meiosis,
as well as plenary sessions. The Carter Lecture will be
given by Professor John Todd on Genetics, etiology,
apoptosis, and natural selection in type 1 diabetes. For
further information, contact the Conference Office, Brit-
ish Society for Human Genetics, Clinical Genetics Unit,
Birmingham Women’s Hospital, Edgbaston, Birming-
ham, B15 2TG; phone/fax: 0121 627 2634; E-mail: bshg
@bham.ac.uk; WWW: http://www.bham.ac.uk/bshg.
MEETING
International Society of Psychiatric Genetics’ 7th World
Congress on Psychiatric Genetics.—To be held October
14–18, 1999, Monterey, CA. Abstracts due May 15,
1999. Qualifies for up to 24 hours of CME Category I
credit. Sample topics include genetic factors and linkage
studies in psychiatric disorders, candidate genes, phar-
macogenetics, and ethical issues in genetics. For more
information, contact Dr. Lynn E. DeLisi, ISPG–Seventh
World Congress, Department of Psychiatry, HSC T-10,
SUNY at Stony Brook, Stony Brook, NY 117948101;
phone (516) 444-7246; fax (516) 444-7536; E-mail:
kgreene@mail.psychiatry.sunysb.ed; WWW: http://www
.uhmc.sunysb.edu/ispg/.
